• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症的诱导化疗。

Induction chemotherapy in the management of head and neck cancer.

机构信息

Head and Neck Medical Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

出版信息

J Surg Oncol. 2010 Mar 15;101(4):292-8. doi: 10.1002/jso.21438.

DOI:10.1002/jso.21438
PMID:20187068
Abstract

The strategy of induction chemotherapy prior to planned definitive local therapy for head and neck squamous cell carcinoma has been studied for over 30 years, and appears to have a role in select clinical situations. Here we review landmark studies regarding induction chemotherapy, both in the pre-taxane era and in the current taxane era, and we address some of the unresolved questions regarding the role of induction chemotherapy in head and neck cancer.

摘要

在头颈部鳞状细胞癌的计划确定性局部治疗之前进行诱导化疗的策略已经研究了 30 多年,并且在某些临床情况下似乎具有一定的作用。在这里,我们回顾了关于诱导化疗的里程碑式研究,包括在紫杉醇前时代和当前的紫杉醇时代,并解决了一些关于诱导化疗在头颈部癌症中的作用的未解决问题。

相似文献

1
Induction chemotherapy in the management of head and neck cancer.头颈部癌症的诱导化疗。
J Surg Oncol. 2010 Mar 15;101(4):292-8. doi: 10.1002/jso.21438.
2
Induction chemotherapy in head and neck cancer: a new paradigm.头颈部癌症的诱导化疗:一种新的范例。
Anticancer Drugs. 2011 Aug;22(7):613-20. doi: 10.1097/CAD.0b013e3283425871.
3
[Use of docetaxel in treatment of squamous-cell carcinoma of head and neck].多西他赛在头颈部鳞状细胞癌治疗中的应用
Vopr Onkol. 2011;57(4):421-6.
4
The role of taxanes and targeted therapies in locally advanced head and neck cancer.紫杉烷类药物和靶向治疗在局部晚期头颈癌中的作用。
Curr Opin Oncol. 2007 May;19(3):195-201. doi: 10.1097/CCO.0b013e3280f00fe7.
5
Development of targeted therapy for squamous cell carcinomas of the head and neck.头颈部鳞状细胞癌的靶向治疗进展。
Expert Rev Anticancer Ther. 2011 Mar;11(3):373-86. doi: 10.1586/era.10.193.
6
Induction chemotherapy: to use or not to use? That is the question.诱导化疗:用还是不用?这是个问题。
Semin Radiat Oncol. 2009 Jan;19(1):11-6. doi: 10.1016/j.semradonc.2008.09.003.
7
Paradigm shift in the treatment of head and neck cancer: the role of neoadjuvant chemotherapy.头颈癌治疗的范式转变:新辅助化疗的作用
Oncologist. 2005;10 Suppl 3:11-9. doi: 10.1634/theoncologist.10-90003-11.
8
Is there still a role for induction chemotherapy for head and neck cancer?诱导化疗在头颈癌治疗中仍有作用吗?
J Clin Oncol. 2005 Feb 20;23(6):1059-60. doi: 10.1200/JCO.2005.09.925. Epub 2005 Jan 18.
9
Docetaxel in the management of patients with head and neck squamous cell carcinoma.多西他赛在头颈部鳞状细胞癌患者治疗中的应用
Expert Rev Anticancer Ther. 2008 Jul;8(7):1023-32. doi: 10.1586/14737140.8.7.1023.
10
Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.包括术后放疗以及每周使用多西他赛进行同步化疗在内的多模式治疗,对于口腔癌和口咽癌患者而言是可行且有效的。
Strahlenther Onkol. 2005 Jan;181(1):26-34. doi: 10.1007/s00066-005-1272-3.

引用本文的文献

1
Phase I study of induction chemotherapy with afatinib, ribavirin, and weekly carboplatin and paclitaxel for stage IVA/IVB human papillomavirus-associated oropharyngeal squamous cell cancer.阿法替尼、利巴韦林与每周一次卡铂和紫杉醇联合诱导化疗用于IVA/IVB期人乳头瘤病毒相关口咽鳞状细胞癌的I期研究
Head Neck. 2018 Feb;40(2):233-241. doi: 10.1002/hed.24938. Epub 2017 Sep 30.
2
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).每周一次白蛋白结合型紫杉醇+每周一次西妥昔单抗+调强放射治疗(IMRT)用于III-IVB期头颈部鳞状细胞癌(HNSCC)患者的I期研究。
Ann Oncol. 2014 Mar;25(3):689-694. doi: 10.1093/annonc/mdt579. Epub 2014 Feb 3.
3
A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer.一项评估依维莫司联合多西他赛和顺铂作为局部晚期和/或区域性头颈部癌患者诱导化疗的 1 期研究。
Cancer. 2013 May 15;119(10):1823-31. doi: 10.1002/cncr.27986. Epub 2013 Feb 13.
4
Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma.多西他赛、顺铂和S-1治疗局部晚期、复发和转移性头颈部鳞状细胞癌的I/II期研究
Oncol Lett. 2012 Nov;4(5):898-904. doi: 10.3892/ol.2012.846. Epub 2012 Aug 6.
5
Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy.弥散加权成像预测诱导化疗治疗头颈部鳞状细胞癌患者无进展生存期。
Acad Radiol. 2011 Oct;18(10):1225-32. doi: 10.1016/j.acra.2011.06.009. Epub 2011 Aug 10.